Accuray Faces Stock Dilution Risk as Warrant Exercises Loom, Threatening Share Value

Accuray Incorporated (ARAY) has disclosed a new risk, in the Share Price & Shareholder Rights category.

Accuray Incorporated faces a significant business risk due to the potential exercise of outstanding warrants, which could lead to an increase in the number of shares available for resale in the public market, thereby diluting the value of existing stockholders’ shares. As of June 30, 2025, a total of 23,428,241 shares could be issued through the exercise of Premium and Penny Warrants, potentially exerting downward pressure on the stock price. This dilution risk might prompt current stockholders to sell their shares, further depressing the stock price and encouraging short selling. Additionally, the anti-dilution provisions in the Warrants could complicate future equity financing efforts, making it challenging for the company to raise funds under favorable conditions.

Overall, Wall Street has a Strong Buy consensus rating on ARAY stock based on 3 Buys.

To learn more about Accuray Incorporated’s risk factors, click here.